Search alternatives:
marked decrease » marked increase (Expand Search)
1 decrease » _ decrease (Expand Search), a decrease (Expand Search), b1 decreased (Expand Search)
34 1 » 3 1 (Expand Search), 04 1 (Expand Search), 4 1 (Expand Search)
marked decrease » marked increase (Expand Search)
1 decrease » _ decrease (Expand Search), a decrease (Expand Search), b1 decreased (Expand Search)
34 1 » 3 1 (Expand Search), 04 1 (Expand Search), 4 1 (Expand Search)
-
1
-
2
Participant characteristics (<i>n</i> = 34).
Published 2024“…<div><p>This study demonstrated the effect of differences in the exterior of erosion control dams (ECDs) on humans. We recruited 34 university students. Participants sat 1.4 m away from the display while wearing a device for measuring heart rate (HR) and heart rate variability. …”
-
3
Infection of CD 34
Published 2025“…Survival curve of HTLV-1-p12stop, and HTLV-1-CTCF infected CD34+ Hu-mice. …”
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
Chromatin accessibility analysis of perinatal Vps34-deficient Tregs.
Published 2025“…AP-1-related transcription factors with predicted decreased activity are labeled. …”
-
13
-
14
-
15
-
16
-
17
Vps34 is essential for terminal differentiation of eTregs during perinatal life.
Published 2025“…(<b>F</b>) GSEA enrichment plots showing increased Vps34-activated signature (upper; i.e., top 200 downregulated genes [log<sub>2</sub>FC < −0.5, <i>P</i> < 0.05]) in Vps34-deficient Tregs versus control Tregs from mixed BM chimeras; see <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3003074#pbio.3003074.s010" target="_blank">S2 Table</a> and <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3003074#sec010" target="_blank">Materials and methods</a> for details) and decreased Vps34-suppressed signature (lower; i.e., top 200 upregulated genes [log<sub>2</sub>FC > 0.5, <i>P</i> < 0.05]) in Vps34-deficient Tregs versus control Tregs from mixed BM chimeras; see <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3003074#pbio.3003074.s010" target="_blank">S2 Table</a> and <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3003074#sec010" target="_blank">Materials and methods</a> for details) in KLRG1<sup>+ </sup>Nfil3<sup>+</sup> terminal Tregs compared to KLRG1<sup>− </sup>Nfil3<sup>+</sup> transitional Tregs (from a public RNA-seq dataset GSE130884 [<a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3003074#pbio.3003074.ref011" target="_blank">11</a>]; see <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3003074#sec010" target="_blank">Materials and methods</a> for details). …”
-
18
-
19
Design, Synthesis, and Biological Evaluation of [1,2,5]Oxadiazolo[3,4‑<i>b</i>]pyridin-7-ol as Mitochondrial Uncouplers for the Treatment of Obesity and Metabolic Dysfunction-Assoc...
Published 2024“…In this study, we disclose the structure–activity relationship profile of 6-substituted [1,2,5]oxadiazolo[3,4-<i>b</i>]pyridin-7-ol derivatives of BAM15. …”
-
20